ST Pharm Competitors and Similar CompaniesClear all
ST Pharm's competitors and similar companies include UCB.
 ST Pharm ST Pharm (formerly known as Samchully Pharmaceutical) is a company that manufactures nucleoside-related pharmaceuticals and intermediates. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1983 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Siheung-si, KR HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 63915% increase | Employees 9,052 |
Financial | ||
Revenue (est.) | Revenue (est.) ₩331.7b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods ₩169.3b (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit ₩162.8b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ₩54.6b (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company